Biolase
Irvine, US · Delaware corporation
Find your way into Biolase
Sign up to see every warm intro you have to Biolase
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Biolase team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Reported raises · per SEC filings
Form D private placements$13.6M disclosed across 3 rounds · 2019–2023
▶$2.7MraisedDec 2023 · 1 investors · Other Health CareRule 506(b)
▶$2.7MraisedDec 2023 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John R. BeaverExecutive Officer, Director
- Jonathan LordDirector
- Kathleen T. O'LoughlinDirector
- Kenneth P. YaleDirector
- Jess RoperDirector
- Jennifer BrightExecutive Officer
- Martha SomermanDirector
- Carol Gomez SummerhaysDirector
- Offering amount
- $2.7M
- Amount sold
- $2.7M
- Sales commissions
- $96K
- Placement agents
- Maxim Group LLC
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.9MraisedJun 2020 · 9 investors · Other Health CareRule 506(b)
▶$6.9MraisedJun 2020 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Richard B. LanmanDirector
- Jess RoperDirector
- Elaine C. WagnerDirector
- Michael DiTollaDirector
- Garrett SatoDirector
- John R. BeaverExecutive Officer
- Jonathan T. LordDirector
- Todd A. NorbeExecutive Officer, Director
- Offering amount
- $6.9M
- Amount sold
- $6.9M
- Sales commissions
- $483.8K
- Placement agents
- The Benchmark Company LLC, Colliers Securities LLC
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4MraisedNov 2019 · 4 investors · Other Health CareRule 506(b)
▶$4MraisedNov 2019 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan T. Lord, M.D.Director
- Elaine C. Wagner, D.D.S.Director
- Garrett SatoDirector
- Jess RoperDirector
- Todd A. NorbeExecutive Officer, Director
- John R. BeaverExecutive Officer
- Richard B. Lanman, M.D.Director
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Biolase raised?
- Biolase has disclosed $13.6M raised across 3 rounds.
- Where is Biolase headquartered?
- Biolase is headquartered in Irvine, US.
